90 related articles for article (PubMed ID: 8821041)
1. The neurochemistry of Parkinson's disease--comments on present and future developments.
Hucho F
J Neural Transm Suppl; 1995; 46():59-65. PubMed ID: 8821041
[TBL] [Abstract][Full Text] [Related]
2. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.
Cai X; Jia H; Liu Z; Hou B; Luo C; Feng Z; Li W; Liu J
J Neurosci Res; 2008 Dec; 86(16):3622-34. PubMed ID: 18709653
[TBL] [Abstract][Full Text] [Related]
3. [Neuroprotective and neurorestorative therapy in Parkinson's disease].
Jiménez-Jiménez FJ; Molina JA
Rev Neurol; 1997 Aug; 25 Suppl 2():S185-93. PubMed ID: 9280687
[TBL] [Abstract][Full Text] [Related]
4. Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress.
Singh C; Ahmad I; Kumar A
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):19-28. PubMed ID: 17543230
[TBL] [Abstract][Full Text] [Related]
5. Potential of gene therapy for pediatric neurotransmitter diseases: lessons from Parkinson's disease.
Kang UJ; Nakamura K
Ann Neurol; 2003; 54 Suppl 6():S103-9. PubMed ID: 12891660
[TBL] [Abstract][Full Text] [Related]
6. Neuronal pathology in Parkinson's disease.
Schulz JB; Falkenburger BH
Cell Tissue Res; 2004 Oct; 318(1):135-47. PubMed ID: 15365812
[TBL] [Abstract][Full Text] [Related]
7. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
8. Targets for gene therapy of Parkinson's disease: growth factors, signal transduction, and promoters.
During MJ; Leone P
Exp Neurol; 1997 Mar; 144(1):74-81. PubMed ID: 9126155
[TBL] [Abstract][Full Text] [Related]
9. Genomic aspects of sporadic Parkinson's disease.
Riederer P; Youdim MB; Mandel S; Gerlach M; Grünblatt E
Parkinsonism Relat Disord; 2008; 14 Suppl 2():S88-91. PubMed ID: 18585078
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective therapy for Parkinson's disease.
Koller WC
Exp Neurol; 1997 Mar; 144(1):24-8. PubMed ID: 9126147
[TBL] [Abstract][Full Text] [Related]
11. Heredity in Parkinson's disease: new findings.
Lev N; Melamed E
Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
[TBL] [Abstract][Full Text] [Related]
12. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
Hodaie M; Neimat JS; Lozano AM
Neurosurgery; 2007 Jan; 60(1):17-28; discussion 28-30. PubMed ID: 17228250
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy in Parkinson's disease.
Eberhardt O; Schulz JB
Cell Tissue Res; 2004 Oct; 318(1):243-60. PubMed ID: 15322915
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
16. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (II)].
Mínguez-Castellanos A; Escamilla-Sevilla F
Rev Neurol; 2005 Dec 1-15; 41(11):684-93. PubMed ID: 16317638
[TBL] [Abstract][Full Text] [Related]
17. Factors involved in the determination of the neurotransmitter phenotype of developing neurons of the CNS: applications in cell replacement treatment for Parkinson's disease.
Riaz SS; Bradford HF
Prog Neurobiol; 2005 Jul; 76(4):257-78. PubMed ID: 16256257
[TBL] [Abstract][Full Text] [Related]
18. Preclinical development of gene therapy for Parkinson's disease.
Porras G; Bezard E
Exp Neurol; 2008 Jan; 209(1):72-81. PubMed ID: 17904121
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and neurotoxicity.
Sayre LM; Perry G; Smith MA
Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
[TBL] [Abstract][Full Text] [Related]
20. Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologies.
Kang UJ
Mov Disord; 1998; 13 Suppl 1():59-72. PubMed ID: 9613721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
